Cargando…
Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
Autores principales: | Kim, Do Young, Lim, Hong Euy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940649/ https://www.ncbi.nlm.nih.gov/pubmed/29671288 http://dx.doi.org/10.4070/kcj.2018.0081 |
Ejemplares similares
-
The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022) -
Esophageal Endoscopy after High-power and Short-duration Ablation in Atrial Fibrillation Patients
por: Shin, Dong Geum, et al.
Publicado: (2020) -
Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019) -
Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021) -
Oral Anticoagulants in Japanese Patients with Atrial Fibrillation and Active Cancer
por: Yasui, Taku, et al.
Publicado: (2019)